- Pharmaceutical companies
- Teijin
Teijin
Phone: +81 3-3506-4055; +81 3-3506-4529
E-mail: pr@teijin.co.jp
Web: https://www.teijin.com/products/health-care/
Type | Public (K.K) |
---|---|
Traded as | TYO: 3401 Nikkei 225 Component |
Industry | Chemicals |
Founded | (June 17, 1918 (1918-06-17)) |
Headquarters | Teijin Building 6-7, Minami-hommachi 1-chome, Chuo-ku, Osaka 541-8587, Japan |
Key people | Jun Suzuki (President and CEO) |
Products |
Products list
|
Revenue | $ 7.64 billion (FY 2013) (¥ 784.42 billion) (FY 2013) |
Net income | $ 81.5 million (FY 2013) (¥ 8.35 billion) (FY 2013) |
Number of employees | 15,756 (consolidated, as of March 31, 2014) |
Website | Official website |
Teijin Limited (帝人株式会社, Teijin Kabushiki-gaisha) is a Japanese chemical, pharmaceutical and nformation technology company. Its main fields of operation are high-performance fibers such as aramid, carbon fibers & composites, healthcare, films, resin & plastic processing, polyester fibers, products converting and IT products. The company is listed on the first section of the Tokyo Stock Exchange and is a constituent of the Nikkei 225 stock index . As of March 2014, the Teijin Group comprises 151 companies, 56 in Japan and 95 overseas. Teijin is a member of the Mitsubishi UFJ Financial Group (MUFJ) keiretsu. Under our brand statement "Human Chemistry, Human Solutions"—our promise to society and our customers, to respond to various global issues and needs, we are focusing on technological innovation in our strengths of high-performance materials, healthcare and IT as well as in overlapping business domains to create and provide value unique to the Teijin Group in the form of solutions.
For detailed contact information visit location pages below.
Teijin's locations around the world
Clinical Trials sponsored by Teijin
-
Teijin America, Inc.TerminadoEnfermedad renal diabéticaEstados Unidos
-
Teijin Pharma LimitedTerminado
-
Teijin America, Inc.TerminadoHernia de disco lumbarEstados Unidos
-
Teijin America, Inc.ParexelTerminadoArtritis ReumatoideEstados Unidos
-
Freed Study GroupTeijin Pharma LimitedDesconocido